Atrial Fibrillation Surgery Market Size

Atrial Fibrillation Surgery Market size was valued at USD 4.1 billion in 2024 and is expected to reach USD 33 billion by 2037, registering around 17.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of atrial fibrillation surgery is assessed at USD 4.67 billion. The growth of the market can be attributed to the increasing number of people suffering from atrial fibrillation. According to reports, in the USA, 2.3 million people suffer from atrial fibrillation and this rate is projected to reach 5.6 million by the year 2050, with more than 50% of these individuals over the age of 80. Further, the advancements in technology in the field of atrial fibrillation surgery are expected to contribute to the growth of the market.

In addition to these, factors that are believed to fuel the market growth of atrial fibrillation surgery include the increased preference to use catheter ablation procedures and products to treat cardiac arrhythmias. Catheter ablation is used especially in conditions where medicines and drugs are not working. For instance, in August 2020, Abbott Laboratories, a manufacturer of healthcare products and medical devices introduced the TactiFlex PAF IDE ablation catheter, which is used to treat a patient suffering from irregular heartbeat, and paroxysmal atrial fibrillation. It has sensors enabled for patients with atrial fibrillation (AFib) symptoms that cannot be treated with medicine. Further, the reduced mortality rate and positive outcomes of atrial fibrillation surgery are predicted to boost market growth in the forecast period.